News

Germany-based biopharmaceutical company Paion and Ergomed Clinical Research, a clinical development company, have reported encouraging data from the open-label Phase IIa study with the N-methyl-D-aspartic acid receptor antagonist

Medifocus, a Canada-based capital pool company, has reported positive clinical results from Phase II breast cancer treatment study that demonstrate significant efficacy when using the company’s proprietary focused

BioStar Pharmaceuticals, a developer and manufacturer of pharmaceutical and medical nutrient products, has reported a net income of $6.69m, or $0.22 per diluted share, for 2008, compared to

Genentech, a biotechnology company, has initiated a phased voluntary withdrawal of the psoriasis drug Raptiva from the US market. The company’s decision is based on the association of

Amarin, a biopharmaceutical company, has announced that the European Medicines Agency has accepted for review the company’s marketing authorization application for AMR101 in patients with Huntington’s disease. The

Most recently, Dr Rioux was chief medical officer (CMO) of FerroKin Biosciences, a developer of iron chelator for treatment of anemias. Prior to that, Dr Rioux was CMO

Othera Pharmaceuticals, a specialty pharmaceutical company, has reported positive interim data from its Phase II trial of OT-551 in treating geographic atrophy, an advanced form of dry age-related

This patent infringement suit was originally filed in 2004 and relates to the use of lasers for endovenous ablation. CoolTouch will license the Navarro patent and pay royalties

Schering-Plough’s majority owned affiliate in India, Fulford India, has received approval for its Viraferonpeg, the pegylated interferon therapy in combination with Rebetol, for retreating adult patients with chronic